On May 12, 2025, ClearPoint Neuro, Inc. completed a stock purchase agreement with investors to sell 275,808 shares at $12.69 each, raising approximately $3.5 million, while also entering into a note purchase agreement for up to $105 million in notes with a variable interest rate, aimed at supporting general corporate purposes.